What is Peptone?
Peptone operates at the intersection of computational physics and molecular biology, specializing in the development of its proprietary protein engineering operating system, PeOS. This advanced platform facilitates the automated identification of non-obvious protein variants possessing desirable therapeutic properties and cost-effective manufacturability. The company's technology is instrumental in advancing a range of pre-clinical and late-stage protein therapeutics programs, positioning Peptone as a key innovator in the biopharmaceutical discovery landscape.
How much funding has Peptone raised?
Peptone has raised a total of $40M across 1 funding round:
Series A
$40M
Series A (2022): $40M with participation from Hoxton Ventures, dRx Capital, Bessemer Venture Partners, and Walden Catalyst Ventures
Key Investors in Peptone
Hoxton Ventures
Hoxton Ventures is an early-stage venture capital firm based in London, focusing on European technology startups with global scaling potential. They typically invest between $500,000 and $5 million in pre-seed and seed-stage companies.
dRx Capital
dRx Capital is a joint venture investment company launched by Qualcomm and Novartis with a $100M fund dedicated to early-stage digital medicine companies, leveraging networks in pharma and mobile/IT.
Bessemer Venture Partners
Bessemer Venture Partners is a venture capital firm with a global presence, established in 1911. They have offices in major tech hubs and invest across various stages of company development.
What's next for Peptone?
With its recent major strategic investment, Peptone is poised to accelerate the expansion of its protein drug discovery engine. The company's focus on automating the search for therapeutically relevant protein variants suggests a trajectory towards enhancing drug development pipelines for partners and internal programs. Future growth is likely to involve scaling its computational capabilities and forging deeper collaborations within the biopharmaceutical sector, leveraging its unique PeOS platform to address unmet medical needs and optimize manufacturing processes for novel protein-based therapies.
See full Peptone company page
